v3.26.1
REVENUE - Schedule of Revenue Concentrations (Details) - Gross product revenue - Customer
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
BioRidge Pharma, LLC        
Disaggregation of Revenue [Line Items]        
Concentration risk (as percent) 76.30% 61.10% 80.30% 62.20%
Cencora, Inc.        
Disaggregation of Revenue [Line Items]        
Concentration risk (as percent) 16.00% 20.50% 16.50% 19.50%
McKesson Corporation        
Disaggregation of Revenue [Line Items]        
Concentration risk (as percent) 14.40% 20.70% 15.00% 19.10%
Cardinal Health, Inc.        
Disaggregation of Revenue [Line Items]        
Concentration risk (as percent) 14.40% 23.40% 13.70% 22.80%
Caremark, LLC        
Disaggregation of Revenue [Line Items]        
Concentration risk (as percent) 13.40% 0.00% 12.80% 0.00%